Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Supriya Lifescience Ltd. Share Price
Day's Range
Day's Range
Low
₹820.00
High
₹845.10
Price Summary
| Previous Close | ₹842.60 |
|---|---|
| Day's Range | ₹820.00 - ₹845.10 |
| Open | ₹832.90 |
| 52 Week Range | ₹545.50 - ₹1,085.00 |
| Volume | 67,161 |
| Market Cap | ₹0.01 |
| Previous Close | ₹844.50 |
|---|---|
| Day's Range | ₹820.05 - ₹845.00 |
| Open | ₹822.45 |
| 52 Week Range | ₹545.65 - ₹1,085.50 |
| Volume | 2,384 |
| Market Cap | ₹0.01 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 565.90 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.12 |
| Price/Earning (TTM) | 32.04 |
| TTM EPS (₹) | 25.98 |
| P/E Ratio | 31.41 |
| Book Value(₹) | 5.59 |
| PAT Margin (%) | 24.04 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 27.63 |
| Trade Value ( ₹ in Lacs) | 20.13 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.12 |
| Price/Earning (TTM) | 32.04 |
| TTM EPS (₹) | 25.98 |
| P/E Ratio | 31.41 |
| Book Value(₹) | 5.59 |
| PAT Margin (%) | 24.04 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 27.63 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 1841.09 | 6964.85 |
| Expenses | N/A | N/A |
| PBT | 640.62 | 2484.81 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 503.82 | 1879.58 |
About Supriya Lifescience Ltd.
| Founded | 2008 |
|---|---|
| Managing Director | Saloni Satish Wagh |
| NSE Symbol | SUPRIYA |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,68,842.05 | 1,939.25 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,93,859.76 | 7,264.20 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,92,686.75 | 4,984.80 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,27,682.21 | 8,814.90 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,12,593.44 | 1,419.55 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,11,082.03 | 1,107.20 | 835.50 - 835.50 |
| Lupin Ltd. | 1,09,553.48 | 2,367.65 | 1,836.80 - 1,836.80 |
| Mankind Pharma Ltd. | 1,05,607.20 | 2,525.35 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 1,05,473.64 | 1,079.10 | 903.00 - 903.00 |
| Dr. Reddy's Laboratories Ltd. | 97,364.93 | 1,156.45 | 1,101.00 - 1,101.00 |
No Records Found
Latest News
Supriya Lifescience informs about newspaper advertisement
Supriya Lifescience informs about disclosure
Pursuant to the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other applicable laws, and in accordance with the Regulation 30 read with Para B of Part A of Schedule III of the Listing Regulations and SEBI circular dated July 13, 2023 SEBI Listing Regulations, Supriya Lifescience has informed that the investigation has been initiated yesterday against Sreekant Sreedharan, General Manager, Sales & Marketing officer of the Company by Special Investigation and Intelligence branch of Customs Department, subsequent to which judicial custody has been granted by CMM court till July 17, 2026. The Company remains committed to maintaining the highest standards of corporate governance and regulatory compliance. The Company is closely monitoring the developments in the case and any further material developments in the matter shall be disclosed to the stock exchanges in accordance with applicable laws and regulations. The details of the case as required under Circular no SEBI/HO/CFD-PoD-1/P/CIR/2023/123 dated 13th July 2023 are enclosed as Annexure A to the disclosure.
The above information is a part of company’s filings submitted to BSE.
Supriya Lifescience informs about analyst meet
Trident Lifeline submits board meeting intimation
Panacea Biotec informs about disclosure
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Supriya Lifescience Ltd. is ₹842.60 as of 2026-07-24.
The market capitalisation of Supriya Lifescience Ltd. is ₹6,700.60 as of 2026-07-23.
The 1-year return of Supriya Lifescience Ltd. is 142.85% as of 2026-07-24.
The P/E ratio of Supriya Lifescience Ltd. is 31.41 as of 2026-07-24.
The 52-week high and low of Supriya Lifescience Ltd. are ₹1,085.00 and ₹545.50, respectively, as of 2026-07-24.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
